LEALI, Daria
 Distribuzione geografica
Continente #
NA - Nord America 1.879
EU - Europa 1.356
AS - Asia 663
SA - Sud America 23
AF - Africa 7
OC - Oceania 5
Totale 3.933
Nazione #
US - Stati Uniti d'America 1.873
PL - Polonia 491
CN - Cina 290
DE - Germania 267
UA - Ucraina 205
SG - Singapore 142
HK - Hong Kong 114
GB - Regno Unito 77
FI - Finlandia 69
RU - Federazione Russa 65
IT - Italia 59
IE - Irlanda 35
TR - Turchia 35
ES - Italia 30
VN - Vietnam 23
BR - Brasile 19
FR - Francia 16
CZ - Repubblica Ceca 15
IN - India 14
IR - Iran 9
SE - Svezia 8
KR - Corea 7
ID - Indonesia 5
AT - Austria 4
AU - Australia 4
CA - Canada 4
MA - Marocco 4
BE - Belgio 3
GE - Georgia 3
NL - Olanda 3
PH - Filippine 3
AZ - Azerbaigian 2
BG - Bulgaria 2
EG - Egitto 2
IL - Israele 2
KG - Kirghizistan 2
LK - Sri Lanka 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AM - Armenia 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
EC - Ecuador 1
GR - Grecia 1
JO - Giordania 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
MU - Mauritius 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
TJ - Tagikistan 1
Totale 3.933
Città #
Warsaw 491
Fairfield 259
Woodbridge 192
Jacksonville 157
Houston 150
Ashburn 144
Ann Arbor 133
Hong Kong 107
Wilmington 106
Seattle 98
Singapore 95
Chandler 92
Cambridge 84
Princeton 64
Beijing 62
Nanjing 46
Dearborn 38
Helsinki 38
Dublin 35
Madrid 30
Istanbul 27
Jinan 27
Brescia 23
Los Angeles 22
Dong Ket 21
Des Moines 18
Nanchang 18
New York 16
Shanghai 16
Shenyang 16
Changsha 15
Hebei 14
Jiaxing 14
Brno 13
Lancaster 12
The Dalles 12
San Mateo 11
Moscow 10
Hangzhou 8
Kunming 8
Milan 7
Nuremberg 7
Nürnberg 7
San Diego 7
Kilburn 6
Verona 6
Haikou 5
Jakarta 5
London 5
Munich 5
Ningbo 5
Tianjin 5
Zhengzhou 5
Ardabil 4
Augusta 4
Boardman 4
Frankfurt am Main 4
Kocaeli 4
Monmouth Junction 4
Baliuag 3
Brussels 3
Leawood 3
Marigliano 3
Phoenix 3
Rabat 3
Santa Clara 3
Tehran 3
Toronto 3
Wandsworth 3
Washington 3
Amasya 2
Baku 2
Bengaluru 2
Berlin 2
Bishkek 2
Bratislava 2
Canberra 2
Cernusco sul Naviglio 2
Charlottesville 2
Colombo 2
Council Bluffs 2
Falkenstein 2
Fort Lauderdale 2
Guangzhou 2
Gunzenhausen 2
Hefei 2
Highland Park 2
Kai Yi Wan 2
Lanzhou 2
Nashville 2
Rome 2
San Francisco 2
Sejong 2
Sofia 2
Songpa-gu 2
Stockholm 2
São Paulo 2
Tashkent 2
Vienna 2
Yuseong-gu 2
Totale 2.934
Nome #
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 249
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 244
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 233
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 213
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 202
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 167
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 163
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 162
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 157
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 147
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 147
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 141
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 123
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 122
Heparin derivatives as angiogenesis inhibitors 112
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 104
Fibroblast growth factor-2 in angiogenesis 100
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 99
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 95
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 95
Role of inflammation in FGF2-driven angiogenesis 93
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement 90
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 90
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 81
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. 75
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 72
FGF2-Antagonist activity of long pentraxin-3 related peptides 72
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 71
FGF2- Antagonist activity of long pentraxin-3 70
Heparin derivatives and semysynthetic biotechnological heparins as angiogenesis inhibitors 68
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 61
Cutting Edge: IL-1beta Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes 56
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 45
Totale 4.019
Categoria #
all - tutte 16.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020234 0 0 0 0 0 0 0 0 0 129 50 55
2020/2021583 18 69 21 83 20 56 19 65 78 45 67 42
2021/2022278 6 65 2 1 1 14 16 14 10 51 23 75
2022/2023253 37 11 23 14 14 54 0 26 31 2 20 21
2023/2024333 21 38 41 17 20 26 15 12 62 13 8 60
2024/2025470 16 11 7 85 62 58 72 52 81 26 0 0
Totale 4.019